DOYLE THOMAS JAMES 4
4 · Kura Oncology, Inc. · Filed Sep 29, 2025
Insider Transaction Report
Form 4
DOYLE THOMAS JAMES
SVP, Finance & Accounting
Transactions
- Award
Common Stock
2025-09-27+24,966→ 114,370 total - Sale
Common Stock
2025-09-29$8.94/sh−4,541$40,607→ 109,829 total
Holdings
- 500(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.